4.6 Article

Axonal Degeneration Is Blocked by Nicotinamide Mononucleotide Adenylyltransferase (Nmnat) Protein Transduction into Transected Axons

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 285, Issue 53, Pages 41211-41215

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.C110.193904

Keywords

-

Funding

  1. National Institutes of Health [NS070053, AG13730, NS065053]
  2. Muscular Dystrophy Association [10040]
  3. Craig H. Neilsen Foundation [124030]
  4. National Institutes of Health Neuroscience Blueprint Center [P30 NS057105]

Ask authors/readers for more resources

Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wld(s)) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provides an opportunity to develop novel agents to treat axonal damage.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available